## EXC: Exelon Corporation - XLU: Utilities

### Executive Summary

No thesis match: MRS_10 -0.1% below STRENGTH zone (3.0-6.0%); PEG 1.99 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($42.18)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Exelon Corporation: Reliable Growth and Long-Term Value**
- Source: TradingView â€” Track All Markets | 20260103T110813 | Bullish | Relevance: 100%
- Exelon Corporation (EXC) is presented as a strong investment choice due to its stable profits, commitment to modernizing its grid, and expansion into clean energy. The company demonstrates consistent growth in revenue and profitability, offers a steady dividend, and is currently valued attractively compared to its peers. Despite risks such as regulation and weather, Exelon's financial health, clear strategy, and moderate upside potential make it appealing for investors seeking stability and long-term value.

**2. D.A. Davidson & CO. Grows Stake in NextEra Energy, Inc. $NEE**
- Source: MarketBeat | 20260105T142029 | Neutral | Relevance: 59%
- D.A. Davidson & Co. increased its stake in NextEra Energy by 6.2% in Q3, now holding over 1 million shares valued at approximately $80.95 million. This comes after CEO Armando Pimentel Jr. sold a significant portion of his shares in November 2025. NextEra Energy reported Q3 EPS of $1.13, beating estimates, but missed revenue expectations, and currently holds a "Moderate Buy" consensus rating with a $91.72 target price.

**3. Ameren Corporation $AEE Shares Bought by Cwm LLC**
- Source: MarketBeat | 20260103T100739 | Neutral | Relevance: 57%
- Cwm LLC significantly increased its holdings in Ameren Corporation by 92.1% in Q3, now owning 24,329 shares. This comes as Ameren beat Q3 earnings estimates with EPS of $2.17 and increased revenue by 24.2%, setting optimistic guidance for FY2026. Despite a CFO stock sale, institutional investors highly favor the stock, with analysts maintaining a "Moderate Buy" rating.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | UBS | $48 | $49 | -2% |
| 2025-12-12 | JP Morgan | $47 | $50 | -6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | UBS | main | Neutral |
| 2025-12-12 | JP Morgan | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($0.34M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.4% (+0.4%)
- Blackrock Inc.: 11.6% (-1.4%)
- State Street Corpora: 6.6% (-0.0%)
- Geode Capital Manage: 2.9% (+1.8%)
- FMR, LLC: 2.8% (+7.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.99 elevated, pricing in significant growth expectations. Forward P/E 15.3x stretched relative to 5% growth. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $44.0B |
| Beta | 0.56 |
| 52W Range | $37.13 - $48.51 |
| Short Interest | 5.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.99 |
| Forward P/E | 15.3 |
| Current P/E | 16.1 |
| YoY Growth | 5.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.1% to -0.1% (+1.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.1pp (needs >3.0% for momentum thesis). Below SMA200 (0.97x), long-term trend not supportive. RSI neutral at 42. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.09% (CS: 38) | Neutral |
| RSI_14 | 42.4 | Neutral |
| MACD Histogram | 0.09 | Bullish |
| vs SMA20 | 0.997x | Below |
| vs SMA50 | 0.964x | Below |
| vs SMA200 | 0.975x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $43.54
- **Stop Loss:** $42.18 (3.1% risk)
- **Target:** $44.90 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 845
- **Position Value:** $36,791.30
- **Portfolio %:** 36.79%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-11 (Est: $0.58)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.78 | $0.86 | +10.5% |
| 2025Q2 | $0.37 | $0.39 | +6.1% |
| 2025Q1 | $0.86 | $0.92 | +6.9% |
| 2024Q4 | $0.59 | $0.64 | +8.0% |

---
*RULE-based L3 | 2026-01-07 09:35 | MRS_10*